TREM2 and Alzheimer disease: Detectable expression of TREM2 was described in peripheral blood mononuclear cells from mild cognitive-impaired patients that later converted to AD (Casati et al., 2018), as well as in blood from subjects with an increased risk to develop dementia in a Japanese cohort (Ohara et al., 2019).